The Lancet

Dr. Louis Falo holds a microneedle array that contains the spike protein that researchers say triggers antibodies against the COVID-19 illness. (Photo: University of Pittsburgh)

Coronavirus Cure?

Pitt’s COVID-19 Vaccine Successful in Trials In two previous viral outbreaks, spanning almost 20 years, researchers at the University of Pittsburgh worked to develop vaccines.   That experience served them well in the race to develop a preventative treatment for the
Read More